1Stanley TH etal.The influence of chronic preperative propranolol therapy on cardiovascular dynamics and narcotic requirements during opraton in patients with coronary artery disease. Can anaesth soc J 1982;29:319-324.
2Geraldk.Mcevoy.AHFS Drug Information.Published by AMERICAN SOCIETY OF HOSTITAL PHARMACISTS.1993.
3Gray RJ etal,use of esmolol in hypertension after cardicsurgery.Am Jcardiol 1985,56:49F-56F.
4Ornstein E etal, A controlled trial of esmolol for the induction of deliberate hypotension J clin Anesth 1988,1:31-5.
5Ornstein Eetal,Deliberate hypotension in patients with intracransial arteniovenous malformation:esmolol compared with isoflurane and sodium nitroprusside.Anesth Analg 1991,72:639-644.
6Blau WS etal,Esmolol is superior to nitroprusside for controlled hypot ension during oral surgery.Anesth Analg 1991,72:S22.
7Miller RD etal, The effects of alphamethydopa, reserpine,guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).Anesthesiology 1968,29:1153-8.
5Turlapaty P,Vary R,Kaplan JA.Nicardipine,a new intravenous calcium antagonist:a review of its pharmacology,pharmacokinetics,and perioperative applications.J Cardiothorac Anesth,1989,3(3):344-355.
6Kovac AL,McKinley C,Tebbe CJ,et al.Comparison of nicardipine versus placebo to control hemodynamic responses during emergence and extubation.J Cardiothorac Vasc Anesth,2001,15 (6):704-709.
7Levitt MA,Dresden GM.The efficacy of esmolol versus lidocaine to attenuate the hemodynamic response to intubation in isolated head trauma patients.Acad Emerg Med,2001,8(1):19-24.
8Sum CY,Yacobi A,Kartzinel R,et al.Kinetics of esmolol,an ultra-short-acting beta blocker,and of its major metabolite.Clin Pharmacol Ther,1983,34(4):427-434.
9Girard D,Shulman BJ,Thys DM,et al.The safety and efficacy of esmolol during myocardial revascularization.Anesthesiology,1986,65(2):157-164.
